Blackrock Dividend Received from Consumer Healthcare JV decreased by 3.2% to $90.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 592.3%, from $13.00M to $90.00M. Over 2 years (FY 2022 to FY 2025), Dividend Received from Consumer Healthcare JV shows an upward trend with a 136.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher dividends indicate strong performance of the underlying joint venture, contributing positively to the bank's non-interest income.
Cash inflows representing the bank's share of profits distributed from a joint venture or equity-method investment. This...
Specific to companies with equity-method investments; peers report this as income from unconsolidated subsidiaries.
pfe_dividend_received_from_consumer_healthcare_jv| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.50M | $17.50M | $17.50M | $17.50M | $20.00M | $162.00M | $155.00M | $27.00M | $22.00M | $13.00M | $249.00M | $35.00M | $93.00M | $90.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +14.3% | +710.0% | -4.3% | -82.6% | -18.5% | -40.9% | >999% | -85.9% | +165.7% | -3.2% |
| YoY Change | — | — | — | — | +14.3% | — | — | — | +10.0% | -92.0% | +60.6% | +29.6% | +322.7% | +592.3% |